Skip to main content

Table 4 Rates of routinely recommended laboratory tests for pregnant women a , and rates of CMV-specific testing among pregnant women a with claims for routinely recommended laboratory tests, MarketScan, 2009

From: Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data

Routinely recommended laboratory tests for pregnant womena Pregnant womena Pregnant womenawith CMV-specific testingb
  # (%) # (%)
Anemia testing 10,033 (13) 146 (1.5)
Glucose testing 54,989 (71) 1,228 (2.2)
Urine testing 54,947 (71) 1,311 (2.4)
Syphilis testing 65,047 (84) 1,613 (2.5)
Chlamydia testing 49,730 (64) 1,225 (2.5)
HIV testing 57,262 (74) 1,530 (2.7)
Hepatitis B testing 23,011 (30) 800 (3.5)
Rubella testing 15,546 (20) 650 (4.2)
  1. Note: CMV, cytomegalovirus; PCR, polymerase chain reaction; IgG, Immunoglobulin G; IgM, Immunoglobulin M; DFA, direct fluorescent testing; EIA, enzyme immunoassay.
  2. aPregnant women defined as female enrollees who were 1) aged 15–44 years, 2) enrolled for the entire year in 2009, and 3) had a delivery code (defined in Appendix) between October-December 2009.
  3. bCMV-specific testing includes CMV IgG, CMV IgM, CMV DFA, CMV EIA, and CMV PCR testing.